ADIAL PHARMACEUTICALS CEO William Stilley's 2019 pay jumps 95% to $2.4M
ADIAL PHARMACEUTICALS reports 2019 executive compensation
By ExecPay News
Published: July 20, 2020
ADIAL PHARMACEUTICALS reported fiscal year 2019 executive compensation information on July 20, 2020.
In 2019, three executives at ADIAL PHARMACEUTICALS received on average a compensation package of $1.4M, a 84% increase compared to previous year.
Average pay of disclosed executives at ADIAL PHARMACEUTICALS
William B. Stilley, Chief Executive Officer, received $2.4M in total, which increased by 95% compared to 2018. 55% of Stilley's compensation, or $1.3M, was in option awards. Stilley also received $382K in salary and $673K in other compensation.
Bankole Johnson, Chief Medical Officer, received a compensation package of $1.1M. 53% of the compensation package, or $582K, was in option awards.
Joseph A. M. Truluck, Chief Financial Officer, earned $727K in 2019, a 136% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on July 20, 2020.